Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease
John Magenau(University of Michigan), Sophie Paczesny(MUSC Hollings Cancer Center), Daniel Bickley(University of Michigan), James L.M. Ferrara(Tisch Hospital), Matthew Schlough(University of Michigan), Isao Tawara(Mie University), John E. Levine(Icahn School of Medicine at Mount Sinai), Xuemei Qin(Shanxi University), Kathleen P. Lowler(University of Michigan), Sung Won Choi(University of Michigan), Pil‐Sang Jang(University of Michigan), Shin Mineishi(University of Alabama at Birmingham), Carrie L. Kitko(Vanderbilt University Medical Center), Pavan Reddy(Wichita State University), Thomas Braun(University of Michigan), Clare Rogers(Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust), Dawn Jones(University of Michigan)
Cited by 142
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598